Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
---|
09/21/2011 | EP2366395A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
09/20/2011 | US8022234 Compounds and compositions |
09/14/2011 | CN102180928A 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof |
09/14/2011 | CN101759740B Method for synthesizing 3-alpha-acetoxy-deoxidized androstane-5-17-ketone |
09/09/2011 | WO2011108661A1 Method for producing silylenol ethers |
09/08/2011 | US20110218162 15-thia steroid compounds and compositions |
09/07/2011 | CN102175750A Method for analyzing biological samples by using matrix assisted laser desorption ionization-Fourier transform ion cyclotron resonance mass spectra |
08/18/2011 | WO2011098439A2 A process for introducing a double bond into position 15,16 of a steroid |
08/18/2011 | US20110201585 The Use of Oestrogen Applied to the Penis to Reduce HIV Infections |
08/18/2011 | CA2787588A1 A process for introducing a double bond into position 15,16 of a steroid |
08/17/2011 | CN101218245B 3-ester prodrugs of ethynylestradiol |
08/11/2011 | US20110195942 Method of making and using 7alpha, 11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate |
08/10/2011 | EP2354150A1 Process for the preparation of gestodene |
08/09/2011 | US7994351 Preparation of bile acids and intermediates thereof |
08/04/2011 | US20110190505 Iodonium Cyclophanes for SECURE Arene Functionalization |
08/04/2011 | DE102010006818A1 Producing drospirenone, useful as hormonal contraceptives, by oxidatively converting hydroxy-dimethylenandrostane-one to hydroxy-dimethylenandrostan-dione, eliminating hydroxy group, followed by reacting with 1-halopropan-3-oxy |
08/03/2011 | EP2350111A1 Processes and intermediates for the production of fulvestrant |
08/02/2011 | US7989436 Estrogenic compounds and pharmaceutical formulations comprising the same |
07/28/2011 | US20110183949 Use of Fulvestrant in the Treatment of Resistant Breast Cancer |
07/27/2011 | CN101445541B N-(methylthio-sulfur carbonyl)-17-steroidal hydrazone compound, preparation and application thereof |
07/27/2011 | CN101160160B A process for the isolation of pharmacologically active principles of vegetable and animal origin |
07/26/2011 | US7985848 Antidiabetic agent, blood glucose control abnormality; ginsenosides Rg3, Rg5, and Rk1 from natural substances |
07/26/2011 | US7985744 Vitamin D derivatives |
07/21/2011 | US20110178052 9-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancer |
07/20/2011 | EP2344515A1 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds |
07/20/2011 | CN102127137A Intermediate compound for use in preparation of androst amino acid ester and synthesis method thereof |
07/19/2011 | CA2487722C New etonogestrel esters |
07/05/2011 | US7973185 Process for the preparation of phenolic hydroxy-substituted compounds |
06/30/2011 | US20110160442 Method for the fractionation of knotwood extract and use of a liquid-liquid extraction for purification of knotwood extract |
06/30/2011 | US20110158947 Sulfonylurea receptor and means for treating ischaemia |
06/28/2011 | CA2529009C Method for obtaining a natural mixture of conjugated equine estrogens |
06/23/2011 | US20110152552 Preparation of bile acids and intermediates thereof |
06/23/2011 | US20110152544 Process for the preparation 2-substituted derivatives of estrone and estradiol |
06/22/2011 | CN101296936B Process for production of steroid compound |
06/21/2011 | US7964586 by solid phase extraction from pregnant mares urine; contacting the urine with polymeric adsorption resins sufficient to adsorb the estrogen derivatives in the urine, then separating the resulting resin loaded with the mixture, washing and eluting the derivatives |
06/16/2011 | US20110144363 Process for obtaining 17-spirolactones in steriods |
06/16/2011 | US20110144072 Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants |
06/16/2011 | US20110144071 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs |
06/09/2011 | US20110137057 Unsaturated Steroid Compounds |
06/03/2011 | WO2011066542A2 6-substituted estradiol derivatives and methods of use |
06/03/2011 | CA2781627A1 6-substituted estradiol derivatives and methods of use |
06/02/2011 | US20110130581 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds |
06/02/2011 | US20110130580 Use of buckysome or carbon nanotube for drug delivery |
05/26/2011 | US20110124894 Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters |
05/25/2011 | CN1849330B Specific glucocorticosteroid compound having anti-inflammatory activity |
05/19/2011 | US20110118225 Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them |
05/18/2011 | EP2322182A1 Androstenol derivatives as androgen receptor modulator |
05/18/2011 | EP1295871B1 Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond |
05/18/2011 | CN102060886A Method for preparing 4, 6-dibenzyl-2, 3-unsaturated glucoside |
05/18/2011 | CN101537344B Monolithic column, preparation method and application thereof |
05/17/2011 | CA2411409C Vitamin d derivatives |
05/11/2011 | CN102050858A Preparation method of 17-prasterone androstane-4-alkene-3-ketone |
05/10/2011 | CA2450359C Dosage regimen and pharmaceutical composition for emergency contraception |
05/10/2011 | CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides |
05/04/2011 | CN102040640A Method for purifying dihydrosarcostin by high-speed counter-current chromatography |
05/04/2011 | CN102040639A Methods for preparing fluoxymesterone and intermediate thereof |
05/03/2011 | US7935838 Process for production of steroid compound |
04/28/2011 | WO2011009529A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
04/28/2011 | US20110098260 Steroid Compounds and Formulations |
04/27/2011 | CN102030797A Technetium-labeled estradiol derivative and reference compound thereof, and preparation method, application and intermediate thereof |
04/27/2011 | CN101362788B High-efficiency synthesis method of 6 alpha-bromo-carboxyandrost-4-ene-3,17-dione |
04/20/2011 | EP2311465A1 Remedies for diseases to be applied to eye |
04/20/2011 | CN101440112B Steroid compound and use thereof |
04/19/2011 | CA2529669C Method for measuring aromatase activity |
04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
03/30/2011 | EP2301549A1 Remedies for diseases to be applied to eye |
03/30/2011 | CN101061132B Method for preparing 17- hydroxy- 6beta, 7beta, 15beta, 16beta- bisacrylamide- 17alpha- pregnane- 4- ene- 3- ketone- 21- carboxylate gamma- lactone and key intermediate used for the said method |
03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
03/23/2011 | EP2069382B1 Process for the selective isolation, purification and separation of monohydroxylated 3,17-diketo-steroid compounds |
03/22/2011 | US7910756 Process for the preparation 2-substituted-derivatives of estrone and estradiol |
03/22/2011 | US7910755 Stem cell expansion and uses |
03/15/2011 | US7906497 Cancer treatment methods |
03/09/2011 | EP2292239A2 Remedies for diseases to be applied to eye |
03/09/2011 | EP1622925B1 Novel method and intermediates for the preparation of 19-nor-steroid compounds |
03/08/2011 | US7901904 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds |
03/02/2011 | CN101982472A Synthesis process of levonorgestrel by methoxydienone |
02/24/2011 | US20110046599 Multi-Day Delivery Of Biologically Active Substances |
02/24/2011 | US20110046402 Novel method and intermediates for preparing 19-norsteroid compounds |
02/22/2011 | US7893284 Oestrogen derivatives as inhibitors of steroid sulphatase |
02/22/2011 | CA2446314C Liver x receptor agonists |
02/16/2011 | EP2284176A1 Process for preparing guggulsterones and guggulsterol |
02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
02/16/2011 | EP2283025A1 5-fluoro-3 ,17 -dihydroxy-5 -androstan-6-one, the method for its production and its use for influencing of plant growth |
02/10/2011 | US20110034429 5a-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR |
02/09/2011 | CN101089011B Process of producing methyltestosterone with Grignard reagent as material |
02/08/2011 | US7884222 Process for the production of tibolone |
02/03/2011 | US20110028711 Unsaturated Steroid Compounds |
01/27/2011 | WO2011009529A2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
01/27/2011 | CA2768448A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
01/26/2011 | CN101353365B Preparation of progestational hormone |
01/25/2011 | CA2441834C Lipid profile modulation |
01/20/2011 | US20110015165 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
01/19/2011 | EP2274316A1 Ligands of estrogen receptors and , method of their preparation and pharmaceuticals comprising them |
01/19/2011 | CN101948495A Preparation method of compound 19-desmethyl-4-androstene-3,17 diketone |
01/13/2011 | US20110009654 11b-fluoro-3-acetoxyestra-3,5-dien-17-one and method for the production thereof |
01/11/2011 | US7868193 Contraceptives; hormone replacement therapy |
01/05/2011 | EP2268655A2 Birch reduction of steroid substrates via alkali metal-silica gel materials |
01/04/2011 | US7863261 androgen receptor modulator; analogs of androst-5-ene-3 beta ,17 beta -diol ("AED") or 1,3,5(10)-estratriene-17 alpha -ethynyl-3 beta ,17 beta -diol ("EED") |
01/04/2011 | CA2220091C Nicotinic acid esters and pharmaceutical compositions containing them |
12/30/2010 | US20100331268 Nitrated Lipids and Methods of Making and Using Thereof |